Mailhot Vega RB - Search Results

1

Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma.

Looi WS, Indelicato DJ, Mailhot Vega RB, Morris CG, Sandler E, Aldana PR, Bradley JA. Looi WS, et al. Among authors: mailhot vega rb. Pediatr Blood Cancer. 2021 Mar;68(3):e28820. doi: 10.1002/pbc.28820. Epub 2020 Nov 23. Pediatr Blood Cancer. 2021. PMID: 33226179

2

Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.

Mailhot Vega RB, Kim J, Bussière M, Hattangadi J, Hollander A, Michalski J, Tarbell NJ, Yock T, MacDonald SM. Mailhot Vega RB, et al. Cancer. 2013 Dec 15;119(24):4299-307. doi: 10.1002/cncr.28322. Epub 2013 Sep 16. Cancer. 2013. PMID: 24105630 Free article.

3

Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.

Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM. Mailhot Vega R, et al. Cancer. 2015 May 15;121(10):1694-702. doi: 10.1002/cncr.29209. Epub 2015 Jan 29. Cancer. 2015. PMID: 25641407 Free article.

4

In Regard to Stecklein et al.

Mailhot Vega RB, Lockney NA, MacDonald SM, Mendenhall NP, Bradley JA. Mailhot Vega RB, et al. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1280-1281. doi: 10.1016/j.ijrobp.2018.11.061. Epub 2019 Mar 13. Int J Radiat Oncol Biol Phys. 2019. PMID: 30900561 No abstract available.

5

The impact of dose algorithms on tumor control probability in intensity-modulated proton therapy for breast cancer.

Liang X, Bradley JA, Zheng D, Rutenberg M, Mailhot Vega R, Mendenhall N, Li Z. Liang X, et al. Phys Med. 2019 May;61:52-57. doi: 10.1016/j.ejmp.2019.04.011. Epub 2019 May 3. Phys Med. 2019. PMID: 31151579

6

Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.

Uezono H, Indelicato DJ, Rotondo RL, Sandler ES, Katzenstein HM, Dagan R, Mendenhall WM, Mailhot Vega R, Brennan BM, Bradley JA. Uezono H, et al. Pediatr Blood Cancer. 2019 Dec;66(12):e27990. doi: 10.1002/pbc.27990. Epub 2019 Sep 16. Pediatr Blood Cancer. 2019. PMID: 31524334

7

45 GyRBE for group III orbital embryonal rhabdomyosarcoma.

Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA. Indelicato DJ, et al. Among authors: mailhot vega rb. Acta Oncol. 2019 Oct;58(10):1404-1409. doi: 10.1080/0284186X.2019.1627412. Epub 2019 Sep 18. Acta Oncol. 2019. PMID: 31530120

8

Using Robust Optimization for Skin Flashing in Intensity Modulated Radiation Therapy for Breast Cancer Treatment: A Feasibility Study.

Liang X, Bradley JA, Mailhot Vega RB, Rutenberg M, Zheng D, Getman N, Norton KW, Mendenhall N, Li Z. Liang X, et al. Among authors: mailhot vega rb. Pract Radiat Oncol. 2020 Jan-Feb;10(1):59-69. doi: 10.1016/j.prro.2019.09.017. Epub 2019 Oct 15. Pract Radiat Oncol. 2020. PMID: 31627030

9

Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma.

Hol MLF, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Lockney NA, Sandler E, Bradley JA. Hol MLF, et al. Among authors: mailhot vega rb. Pract Radiat Oncol. 2020 Jan-Feb;10(1):53-58. doi: 10.1016/j.prro.2019.10.002. Epub 2019 Oct 16. Pract Radiat Oncol. 2020. PMID: 31629089

10

Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.

Kharod SM, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Morris CG, Bradfield S, Sandler ES, Bradley JA. Kharod SM, et al. Among authors: mailhot vega rb. Pediatr Blood Cancer. 2020 Feb;67(2):e28080. doi: 10.1002/pbc.28080. Epub 2019 Nov 17. Pediatr Blood Cancer. 2020. PMID: 31736243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page